The effect or cobra venom factor (CVJ) activation of the complement cascade on leukocyte circadian variation in the rat
Hoopes, P.C.; McCall, C.E.
Experientia 33(2): 224-226
1977
ISSN/ISBN: 0014-4754 PMID: 844566 Document Number: 121250
Document emailed within 1 workday
Related Documents
Fearon, D.T.; Austen, K.F.; Ruddy, S. 1973: Serum proteins involved in decay and regeneration of cobra venom factor-dependent complement activation Journal of Immunology 111(6): 1730-1736Pang, A.S.; Minta, J.O. 1980: Inhibition of vitamin D2-induced arteriosclerosis in rats by depletion of complement with cobra venom factor Artery 7(2): 109-122
Shiau Lin, S.Y.; Su, S.C.; Lee, C.Y. 1976: Comparative studies on cytotoxin from the Indian cobra venom and cardiotoxin from the Formosan cobra venom, with special reference to the effect on the growth of Ehrlich ascites tumor cells in mice Journal of the Formosan Medical Association 75(6): 328-336
Peng, M.H.; Meng, K.W.; Yang, D.H. 2001: The effect of Chinese cobra venom factor on guinea pig to rat cardiac xenotransplantation Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 15(4): 240-243
Hancock, W.W.; Blakely, M.L.; Van der Werf, W.; Bach, F.H. 1993: Rejection of guinea pig cardiac xenografts post-cobra venom factor therapy is associated with infiltration by mononuclear cells secreting interferon-gamma and diffuse endothelial activation Transplantation Proceedings 25(5): 2932
Seelig, R.; Seelig, H.P. 1975: The possible role of serum complement system in the formal pathogenesis of acute pancreatitis II. Cobra venom factor pancreatitis--sodiumtaurocholate and deoxycholate pancreatitis Acta Hepato-Gastroenterologica 22(5): 335-346
Kemp, E.; Steinbrüchel, D.; Starklint, H.; Larsen, S.; Henriksen, I.; Dieperink, H. 1987: Renal xenograft rejection: prolonging effect of captopril, ACE-inhibitors, prostacyclin, and cobra venom factor Transplantation Proceedings 19(6): 4471-4474
Kim, Y.; Pallansch, M.; Carandente, F.; Reissmann, G.; Halberg, E.; Halberg, F.; Halberg, F. 1980: Circadian and circannual aspects of the complement cascade - new and old results, differing in specificity Chronobiologia 7(2): 189-204
Shobonov, B.B.; Kozlov, L.V.; Antonov, V.K. 1989: Complement-inhibiting acidic factors from the venom of Central Asian cobra Naja naja oxiana Biokhimiia 54(12): 2054-2060
Martinelli, G.P.; Matsuda, T.; Waks, H.S.; Osler, A.G. 1978: Studies on immunosuppression by cobra venom factor. III. on early responses to sheep erythrocytes in C5-deficient mice Journal of Immunology 121(5): 2052-2055
Kobayashi, T.; Taniguchi, S.; Ye, Y.; Niekrasz, M.; Kosanke, S.; Neethling, F.A.; Wright, L.J.; Rose, A.G.; White, D.J.; Cooper, D.K. 1996: Delayed xenograft rejection in C3-depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor Transplantation Proceedings 28(2): 560
Li, Z-dong.; Shi, C-qing.; Zhang, Q-hua.; Xiong, Y-liang.; Zhou, X-ding.; Wang, W-yu.; Song, N. 2004: Mechanisms of purified cobra venom factor in preventing hyperacute rejection following discordant liver xenotransplantation in rats Zhonghua Yi Xue Za Zhi 84(23): 2007-2010
Miles, C.W.; Wong, N.P.; Rumpler, W.V.; Conway, J. 1993: Effect of circadian variation in energy expenditure, within-subject variation and weight reduction on thermic effect of food European Journal of Clinical Nutrition 47(4): 274-284
Kurpiewski, G.; Campbell, B.J.; Forrester, L.J.; Barrett, J.T. 1981: Alternate complement pathway activation by recluse spider venom International Journal of Tissue Reactions 3(1): 39-45
Zhang, X.-J.; Ke, L.-M.; Yang, J.; Lin, L.-W.; Xue, E.-S.; Wang, Y.; Yu, L.-Y.; Chen, Z.-K. 2012: Development, characterization and anti-tumor effect of a sequential sustained-release preparation containing ricin and cobra venom cytotoxin Die Pharmazie 67(7): 618-621
Tan, N.H.; Arunmozhiarasi, A. 1989: The anticoagulant activity of Malayan cobra (Naja naja sputatrix) venom and venom phospholipase A2 enzymes Biochemistry International 19(4): 803-810
Gale, R.J.; Nikoloutsopoulos, A.; Bradley, J.; Roberts-Thomson, P.J. 1985: Immune complex activation of neutrophils and enhancement of the activation by rheumatoid factor and complement Journal of Rheumatology 12(1): 21-26
Mold, C.; Gewurz, H. 1980: Activation of human complement by liposomes: serum factor requirement for alternative pathway activation Journal of Immunology 125(2): 696-700
Krasnoselskaya-Riz, I.; Spruill, A.; Chen, Y.-W.; Schuster, D.; Teslovich, T.; Baker, C.; Kumar, A.; Stephan, D.A. 2002: Nuclear factor 90 mediates activation of the cellular antiviral expression cascade Aids Research and Human Retroviruses 18(8): 591-604
Juhl, H.; Sievers, M.; Baltzer, K.; Helmig, F.; Wolf, H.; Brenner, W.; Kalthoff, H. 1995: A monoclonal antibody-cobra venom factor conjugate increases the tumor-specific uptake of a 99mTc-labeled anti-carcinoembryonic antigen antibody by a two-step approach Cancer Research 55(23 Suppl): 5749s-5755s